Search Results - subject:"bioequivalence"

Quality regulation and competition : evidence from pharmaceutical markets

Atal, Juan Pablo; Cuesta, José Ignacio; Sæthre, Morten - 2022

Persistent link: https://www.econbiz.de/10013365951

Quality regulation and competition : evidence from pharmaceutical markets

Atal, Juan Pablo; Cuesta, Jose Ignacio; Sæthre, Morten - 2019 - This version: July 15, 2019

Persistent link: https://www.econbiz.de/10012102639

Quality regulation and competition : evidence from pharmaceutical markets

Atal, Juan Pablo; Cuesta, José Ignacio; Sæthre, Morten - 2019

Persistent link: https://www.econbiz.de/10012182898

Generics substitution, bioequivalence standards, and oversight of international pharmaceutical producers: Complex issues facing the FDA

Mathur, Aparna; Bate, Roger - American Enterprise Institute - 2015

conclude that increased transparency as well as the updating of FDA bioequivalence standards may be important to overcome some …

Persistent link: https://www.econbiz.de/10011273206

Contemporary generic market in Japan – key conditions to successful evolution

Mihajlo B, Jakovljevic; Nakazono, S; Ogura, S - Center for Intergenerational Studies, Institute of … - 2014

Japanese pharmaceutical market, world’s 2nd largest in size, is traditionally renowned for its brands’ domination and weakest generics share among major established economies. An in depth observation of published evidence in Japanese/English language provided closer insight into current...

Persistent link: https://www.econbiz.de/10010737310

Names and Games

Senn, Stephen - In: Rationality, Markets and Morals 3 (2012) 3

Persistent link: https://www.econbiz.de/10010535644

Statistical and regulatory considerations in assessments of interchangeability of biological drug products

Tóthfalusi, Lászlo; Endrényi, László; Shein-chung, Chow - In: The European journal of health economics : HEPAC ; … 15 (2014), pp. 5-11

Persistent link: https://www.econbiz.de/10010376468

Statistical and regulatory considerations in assessments of interchangeability of biological drug products

Tóthfalusi, Lászlo; Endrényi, László; Chow, Shein-Chung - In: The European Journal of Health Economics 15 (2014) 1, pp. 5-11

interchangeability and their statistical implementation; the relation between bioequivalence and interchangeability for small …

Persistent link: https://www.econbiz.de/10010993866

Effect size for comparing two or more normal distributions based on maximal contrasts in outcomes

Ling, Yan; Nelson, Paul - In: Statistical Methods and Applications 23 (2014) 3, pp. 381-399

Effect size is a concept that can be especially useful in bioequivalence and studies designed to find important and not …

Persistent link: https://www.econbiz.de/10010949820

Optimal confidence sets for testing average bioequivalence

Tseng, Yu-Ling - In: TEST: An Official Journal of the Spanish Society of … 11 (2002) 1, pp. 127-141

Persistent link: https://www.econbiz.de/10005390596